Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,021,048
-
Total 13F shares
-
35,134,647
-
Share change
-
+6,542,730
-
Total reported value
-
$685,755,808
-
Put/Call ratio
-
90%
-
Price per share
-
$19.52
-
Number of holders
-
129
-
Value change
-
+$88,658,017
-
Number of buys
-
70
-
Number of sells
-
70
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q1 2016
As of 31 Mar 2016,
Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,134,647 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Point72 Asset Management, L.P., VANGUARD GROUP INC, STATE STREET CORP, FMR LLC, BlackRock Fund Advisors, CITADEL ADVISORS LLC, Jefferies Group LLC, venBio Select Advisor LLC, and COLUMBIA WANGER ASSET MANAGEMENT LLC.
This page lists
129
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.